Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Sanofi eyes approval of COVID-19 vaccine by first half of 2021
Sanofi, which is hosting a virtual research and development event, and GSK had said in April the vaccine, if successful, would be…
G1 Therapeutics and Genor Biopharma sign agreement for Lerociclib
As per the exclusive license agreement, Genor to lead clinical development, regulatory submissions and commercialisation of…
Morepen Labs clocks double-digit growth in its sales and net profit in FY 2019-20
Consolidated Profit before Tax (PBT) recorded extraordinary growth by 34 per cent at Rs. 39.11 crore, up from Rs. 29.18 crore in…
Aurobindo Pharma plans to launch 50-60 products in US in FY21
Aurobindo Pharma's US business posted a growth of 27 per cent year-on-year to Rs 11,484 crore in FY20.
Small market cap companies more dependent on COVID-19 pipeline drug: GlobalData
The small-cap bio/pharma companies without a COVID-19 drug, on average, declined by 19.4 per cent
It’s time to be more vigilant and quality conscious
Dr Ashok Omray, Advisor Pharma Operations, Ex AVP, USV and Ex-President, ICPL shares how crucial it is to ensure that quality…
Antibody levels in recovered COVID-19 patients decline quickly: research
The research highlights the risks of using COVID-19 ‘immunity passports’ and supports the prolonged use of public health…
Thai trials of COVID-19 vaccine reach make-or-break stage
Thirteen monkeys were immunized and the next two weeks will be critical in determining whether researchers can proceed with…
Intravacc’s experimental whooping cough vaccine shows promising results in a preclinical study
The study shows that intranasal immunization induced both excellent systemic and local immune responses, but also prevented…
Alembic Pharma gets tentative US FDA nod for generic Rivaroxaban tablets
The tablet is the generic of Janssen Pharmaceuticals's reference listed drug product Xarelto